Article

Access to the text (HTML) Access to the text (HTML)
PDF @@113110@@
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Annales de Dermatologie et de Vénéréologie
Vol 132, N° HS3  - décembre 2005
pp. 99-
Doi : AD-10-2005-132-HS3-0151-9638-101019-200515579
BULLES ET AFFECTIONS MUQUEUSES : C10 - C18

Traitement de la pemphigoïde bulleuse par corticothérapie locale forte et méthotrexate : résultats d'une enquête rétrospective multicentrique
 

S MERLET [1], H MAILLARD [2], C BEDANE [3], P BERNARD [4], E ESTEVE [5], MA RICHARD [6], P JOLY [7], O DEREURE [8]
[1] Service de Dermatologie, Hôpital Saint-Eloi, Montpellier
[2] Dermatologie, Centre Hospitalier, Le Mans
[3] Dermatologie, CHRU Dupuytren, Limoges
[4] Dermatologie, Hôpital Robert Debré, Reims
[5] Dermatologie, Centre Hospitalier, Orléans
[6] Dermatologie, Hôpital Sainte-Marguerite, Marseille
[7] Dermatologie, Hôpital Charles Nicolle, Rouen
[8] Dermatologie, Hôpital Saint-Eloi, Montpellier, France.


Mots clés : Pemphigoïde bulleuse (DC + MTX)






© 2005 Elsevier Masson SAS. Tous droits réservés.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline